18.9 C
New York
Wednesday, April 24, 2024

Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

Courtesy of Benzinga.

Related JAZZ
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs
JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

Citing three industry bankers, dealReporter is saying that If Allergan, Inc. was looking for a defensive deal, Jazz Pharmaceuticals (NASDAQ: JAZZ) would likely be most viable target.

Shares of Jazz, which have been the subject of much speculation lately, are getting a big lift on the news, trading higher by 6.8 percent at $167.64. Allergan is also higher by 0.78 percent at $166.80.

Posted-In: News Rumors

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,326FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x